PN

Pallavi Namdevravji Mohale

Active Director Director DIN 11533272
DIN 11533272 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Pallavi Namdevravji Mohale

Data last updated:

Pallavi Namdevravji Mohale is a Director at Vidharbha Remedies Private Limited (since 2026). The company operates in Pharma.

DIN 11533272
Primary Designation Director
Industry Pharma
First Appointment 09 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vidharbha Remedies Private Limited U47720MH2026PTC467809
Director09 Feb 20262026Active

Board colleagues of Pallavi Namdevravji Mohale

NameDINCompanyDesignation
Nikhil Prabhakar Pathankar11533273Vidharbha Remedies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vidharbha Remedies Private Limited
Premium access

Shareholding and investment profile for Pallavi Namdevravji Mohale

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pallavi Namdevravji Mohale

Pallavi Namdevravji Mohale currently holds 1 directorship: Vidharbha Remedies Private Limited (Director, since 09 Feb 2026).

Pallavi Namdevravji Mohale was first appointed on 09 Feb 2026 as Director at Vidharbha Remedies Private Limited.

The current boards of Pallavi Namdevravji Mohale's companies include Nikhil Prabhakar Pathankar (Vidharbha Remedies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available